Pharmaceutical Technology

NOVEMBER 9, 2022

In the EU however, two years later, the European Commission awarded a conditional marketing authorisation for Roctavian. BioMarin previously said that the treatment’s European price would likely be around EUR1.5 million price tag. The post Can gene therapies for haemophilia defend their high price tags?

Gene Therapy 278

Gene Therapy Gene FDA Approval Medicine 278

Sciensano

MAY 18, 2022

Members of Belgian and foreign universities, sister institutes, competent authorities, the European Commission and private companies were present, as well as participants from all scientific directions of Sciensano. BE READY project coordinator, Transversal activities in Applied Genomics ( TAG )). Dr. Kevin Vanneste ( TAG ).

Genome 52

Genome Genomics Research 52

pharmaphorum

AUGUST 25, 2022

Tecvayli (teclistamab) has been approved by the European Commission for adults with the blood cancer whose disease has progressed have after at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 antibody, said J&J.

Antibody 98

Antibody Marketing Drugs Medicine 98

pharmaphorum

APRIL 5, 2022

Immunocore now has approval on both side of the Atlantic for Kimmtrak – the first cancer therapeutic based on T cell receptor (TCR) technology – after getting a green light from the European Commission. The European population is meanwhile estimated at several thousand patients, across all stages, according to registry data.

Sales 52

Sales Protein Drugs Trials 52

pharmaphorum

JUNE 2, 2022

This is why the action by the US in 1983 and subsequently the European Commission Regulation No. While in 2021, orphan drugs made up over half of all the US FDA’s approvals, with the figures in European being similarly high – 19 out of 54 approved new active substances. It is estimated that between 3.5 Raising questions.

Drugs 52

Drugs Sales Marketing Development 52

Drug Discovery World

MAY 22, 2023

But are these price tags a barrier to access? Simply, yes, as we saw when the European Commission rejected the price point for bluebird bio’s Zynteglo. The cost 2022 has not been shy of approvals – Uniqure and CSL’s Haemophilia B drug even nabbed the title of “Most Expensive Drug” at $3.5 million per dose.

Gene Therapy 52

Gene Therapy Gene Drugs Contamination 52

The Pharma Data

JANUARY 31, 2021

Utilizing Clover’s proprietary Trimer-Tag© technology, S-Trimer is a trimeric SARS-CoV-2 spike (S)-protein subunit vaccine candidate. About Trimer-Tag© Technology. Trimer-Tag© is an innovative drug development platform which allows the production of novel, covalently-trimerized fusion proteins.

Vaccination 52

Vaccination Vaccine Trials Protein 52